{"version":"1.0","type":"link","title":"Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradation.","author_name":"Luo G 외","author_url":"https://prs-insight.online/author/Luo%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95797","thumbnail_width":1200,"thumbnail_height":630}